Hypera S.A.
Hypera S.A. (HYPMY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HYPMY · as of Jun 8, 2026
Key Statistics
Explore Hypera S.A. Data
hypmy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
hypmy competitorsHYPMY
APNHF
APNHY
BVNKF
BVNRY
DMPHFStock Performance
Full HistoryAbout Hypera S.A.
Hypera S.A. is a prominent pharmaceutical enterprise primarily operating within Brazil. The company maintains a diverse product portfolio that includes a vast array of prescription medications, market…
what is hypera s.a. · hypmy stock overview · hypera s.a. company profile · who is hypera s.a. ceo · hypmy OTC · hypera s.a. headquarters · hypera s.a. business segments
About Stock Overview & Key Data
Hypera S.A. (HYPMY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Oct 15, 2010. As of the latest trading session, HYPMY stock price is $3.96, with a market capitalization of $2.8B. The stock has returned -19.35% over the past 12 months and -4.35% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Hypera S.A. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Hypera S.A. reported revenue of $7.7B and net income of $1.2B. For detailed data — including Hypera S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hypera S.A. (HYPMY) stock price is $3.96. The stock is traded on OTC under the ticker symbol HYPMY. The 52-week range is $3.71 – $5.50.